威海路坦制药有限公司
Weihai Lotus
Weihai Partnering Products Manufacturing People Employment Contacts Home
Weihai Lotus Pharmaceuticals Company is a successful and
rapidly growing wholly owned subsidiary of the Lotus Healthcare Group. The
Company has its modern manufacturing base in Weihai City which
is some one hours flying time from either Beijing or Shanghai, located in the
eastern coastal Province of Shandong. The facility is a modular non-sterile
solid dosage form manufacturing plant designed to cope with the company's growth
and with sufficient spare capacity for additional product forms.
Sales and marketing is done by the company's own growing sales force of over sixty professional medical and sales representatives located around the country and by selected specialized selling agents. Sales management is headquartered in the Beijing office with additional sales offices in Weihai and Guangzhou. Weihai Lotus products are sold in over 1,300 hospitals in 19 Provinces.
Weihai Lotus manufactures and markets Galake® and Lutilium® and is licensed by the China Authorities to import Dihydrocodine API and Oxycodone API. A sustained release morphine sulphate tablet is in the final stage of comparitive clinical trials and is expected to be launched in 2013. Development work on future products containing hydrocodone, naloxone and naltrexone is in the pipeline.
The company was one of the first to be certified by the SFDA as GMP compliant. Certification being valid for five years the company has since successfully undergone two further inspections. The Weihai site occupies an area of four acres and includes pharmaceutical production, office buildings, warehousing and analytical and product development laboratories with a total built up area of 13,000 m². By carefully selecting locally produced equipment and importing some of the main production equipment the right blend of cost containment, high quality and reliability has been achieved.
Click here to visit our Lotus Healthcare website
Your Healthcare Partner in China